Bioprocess Validation Market – Global Industry Analysis and Forecast (2023-2029)


Bioprocess Validation Market is expected to reach USD 706.61 Mn. by 2029 at a CAGR of 14.2% during the forecast period.

The report includes the analysis of impact of COVID-19 lock-down on the revenue of market leaders, followers, and disrupters. Since lock down was implemented differently in different regions and countries, impact of same is also different by regions and segments. The report has covered the current short term and long term impact on the market, same will help decision makers to prepare the outline for short term and long term strategies for companies by region.Bioprocess Validation MarketTo know about the Research Methodology:-Request Free Sample Report

Bioprocess Validation Market Drivers and Restrains:

Global Bioprocess Validation Market are driven by Stringent safety and quality regulations governing product certification and testing across the biopharmaceutical and pharmaceutical industries, high demand for the outsourcing of Bioprocess Validation Market services, and regulatory mandates in the healthcare industry to maintain compliance with good manufacturing practices. Additionally, increasing awareness about the advantages of biopharmaceutical drugs, and the growing number of CROs & CDMOs, the favorable government initiatives to promote the growth of the pharmaceutical and biotechnology industries in several countries such factors are propel the market growth during forecast period.

Bioprocess Validation Market Regional Analysis

Geographically, Global market is segmented into APAC, North America, Europe, and MEA & Africa. APAC is anticipated to exhibit largest market share of xx% CAGR during forecast period. The increasing number of biopharmaceutical manufacturing capabilities in Asian countries, increasing demand for outsourcing Bioprocess Validation Market, growing life science research and development specific by pharmaceutical and biotechnology companies is expected to drive market growth in APAC.

Bioprocess Validation Market Segment Analysis

Based on End Users End-User Global Bioprocess Validation Market is segmented into CDMO, Biotechnology and Pharmaceutical Companies. Pharmaceutical companies are expected to be the largest end users of Bioprocess Validation Market during forecast period. The large share of this segment can majorly be attributed to increasing production of biopharmaceuticals and the corresponding increase in the number of impurities to be checked for, the stringency of standards and regulations regarding the quality and validity of bioprocesses involved in the production.

Bioprocess Validation Market Key Highlights

Global market analysis and forecast, in terms of value.

Comprehensive study and analysis of market drivers, restraints and opportunities influencing the growth of the Global market

Global market segmentation on the basis of type, source, end-user, and region (country-wise) has been provided.

Global market strategic analysis with respect to individual growth trends, future prospects along with the contribution of various sub-market stakeholders have been considered under the scope of study.

Global market analysis and forecast for five major regions namely North America, Europe, Asia Pacific, the Middle East & Africa (MEA) and Latin America along with country-wise segmentation.

Profiles of key industry players, their strategic perspective, market positioning and analysis of core competencies are further profiled.

Competitive developments, investments, strategic expansion and competitive landscape of the key players operating in the Global market are also profiled.

Bioprocess Validation Market Scope: Inquire before buying






Bioprocess Validation Market




Report Coverage
Details




Base Year:
2022
Forecast Period:
2023-2029




Historical Data:
2018 to 2022
Market Size in 2022:
US $ 278.94 Mn.




Forecast Period 2023 to 2029 CAGR:
14.2%
Market Size in 2029:
US $ 706.61 Mn.




 Segments Covered:
by Test Type
Extractables and Leachables
Integrity Testing
Microbiology Testing




by Process Component
Filter Element
Bioreactors




by End-User
CDMO
Biotechnology
Pharmaceutical






Bioprocess Validation Market by Region:

North America (United States, Canada and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina Rest of South America)

Bioprocess Validation Market Major Players:

1.Merck KGaA (Germany)
2.SGS S.A. (Switzerland)
3.Eurofins Scientific (Luxembourg)
4.Sartorius Stedim Biotech (France)
5.Pall Corporation (US)
6.Cobetter Filtration Equipments Co., Ltd. (China)
7.Toxikon Corporation (US)
8.DOC S.r.l. (Italy)
9.MEISSNER FILTRATION PRODUCTS, INC. (US)
10.Thermo Fisher Scientific (US)
11.Danher Corporation
12.Porvair Plc
13.Almac Group
14.Biozeen
15.Werum IT Solutions
16.Eurofins Spinnovation Analytical
17.BioPharm Process Associates, LLC

Frequently Asked Questions:

1. Which region has the largest share in Global Bioprocess Validation Market?
Ans: Asia Pacific region held the highest share in 2022.

2. What is the growth rate of Global Bioprocess Validation Market?
Ans: The Global market is growing at a CAGR of 14.2% during forecasting period 2023-2029.

3. What is scope of the Global Bioprocess Validation market report?
Ans: Global market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period.

4. Who are the key players in Global market?
Ans: The important key players in the Global market are – Merck KGaA (Germany), SGS S.A. (Switzerland), Eurofins Scientific (Luxembourg), Sartorius Stedim Biotech (France), Pall Corporation (US), Cobetter Filtration Equipments Co., Ltd. (China), Toxikon Corporation (US), DOC S.r.l. (Italy), MEISSNER FILTRATION PRODUCTS, INC. (US), Thermo Fisher Scientific (US), Danher Corporation, Porvair Plc, Almac Group, Biozeen, Werum IT Solutions, Eurofins Spinnovation Analytical, BioPharm Process Associates, and LLC

5. What is the study period of this market?
Ans: The Global market is studied from 2022 to 2029. 





Global Bioprocess Validation Market

1. Preface
1.1. Report Scope and Market Segmentation
1.2. Research Highlights
1.3. Research Objectives

2. Assumptions and Research Methodology
2.1. Report Assumptions
2.2. Abbreviations
2.3. Research Methodology
2.3.1. Secondary Research
2.3.2. Secondary data
2.3.3. Secondary Sources
2.3.4. Primary Research
2.3.5. Data from Primary Sources
2.3.6. Breakdown of Primary Sources

3. Executive Summary: Global Bioprocess Validation Market , by Market Value (US$ Bn)

4. Market Overview
4.1. Introduction
4.2. Market Indicator
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.2.4. Challenges
4.3. Porter’s Analysis
4.4. Value Chain Analysis
4.5. Market Risk Analysis
4.6. SWOT Analysis
4.7. Industry Trends in Global Bioprocess Validation Market and Emerging Technologies
4.8. Global Bioprocess Validation Market Competitive Landscape

5. Supply Side and Demand Side Indicators

6. Global Bioprocess Validation Market Analysis and Forecast
6.1. Global Bioprocess Validation Market Size & Y-o-Y Growth Analysis
6.1.1. North America
6.1.2. Europe
6.1.3. Asia Pacific
6.1.4. Middle East & Africa
6.1.5. South America

7. Global Bioprocess Validation Market Analysis and Forecast, By Test Type
7.1. Introduction and Definition
7.2. Key Findings
7.3. Global Bioprocess Validation Market Value Share Analysis, By Test Type
7.4. Global Bioprocess Validation Market Size (US$ Bn) Forecast, By Test Type
7.5. Global Bioprocess Validation Market Analysis, By Test Type
7.6. Global Bioprocess Validation Market Attractiveness Analysis, By Test Type

8. Global Bioprocess Validation Market Analysis and Forecast, By Process Component
8.1. Introduction and Definition
8.2. Key Findings
8.3. Global Bioprocess Validation Market Value Share Analysis, By Process Component
8.4. Global Bioprocess Validation Market Size (US$ Bn) Forecast, By Process Component
8.5. Global Bioprocess Validation Market Analysis, By Process Component
8.6. Global Bioprocess Validation Market Attractiveness Analysis, By Process Component

9. Global Bioprocess Validation Market Analysis and Forecast, by End User
9.1. Introduction and Definition
9.2. Key Findings
9.3. Global Bioprocess Validation Market Value Share Analysis, by End User
9.4. Global Bioprocess Validation Market Size (US$ Bn) Forecast, by End User
9.5. Global Bioprocess Validation Market Analysis, by End User
9.6. Global Bioprocess Validation Market Attractiveness Analysis, by End User

10. Global Bioprocess Validation Market Analysis, by Region
10.1. Global Bioprocess Validation Market Value Share Analysis, by Region
10.2. Global Bioprocess Validation Market Size (US$ Bn) Forecast, by Region
10.3. Global Bioprocess Validation Market Attractiveness Analysis, by Region

11. North America Bioprocess Validation Market Analysis
11.1. Key Findings
11.2. North America Bioprocess Validation Market Overview
11.3. North America Bioprocess Validation Market Value Share Analysis, By Test Type
11.4. North America Bioprocess Validation Market Forecast, By Test Type
11.4.1. Extractables and Leachables
11.4.2. Integrity Testing
11.4.3. Microbiology Testing
11.5. North America Bioprocess Validation Market Value Share Analysis, By Process Component
11.6. North America Bioprocess Validation Market Forecast, By Process Component
11.6.1. Filter Element
11.6.2. Bioreactors
11.7. North America Bioprocess Validation Market Value Share Analysis, by End User
11.8. North America Bioprocess Validation Market Forecast, by End User
11.8.1. CDMO
11.8.2. Biotechnology
11.8.3. Pharmaceutical
11.9. North America Bioprocess Validation Market Value Share Analysis, by Country
11.10. North America Bioprocess Validation Market Forecast, by Country
11.10.1. U.S.
11.10.2. Canada
11.11. North America Bioprocess Validation Market Analysis, by Country
11.12. U.S. Bioprocess Validation Market Forecast, By Test Type
11.12.1. Extractables and Leachables
11.12.2. Integrity Testing
11.12.3. Microbiology Testing
11.13. U.S. Bioprocess Validation Market Forecast, By Process Component
11.13.1. Filter Element
11.13.2. Bioreactors
11.14. U.S. Bioprocess Validation Market Forecast, by End User
11.14.1. CDMO
11.14.2. Biotechnology
11.14.3. Pharmaceutical
11.15. Canada Bioprocess Validation Market Forecast, By Test Type
11.15.1. Extractables and Leachables
11.15.2. Integrity Testing
11.15.3. Microbiology Testing
11.16. Canada Bioprocess Validation Market Forecast, By Process Component
11.16.1. Filter Element
11.16.2. Bioreactors
11.17. Canada Bioprocess Validation Market Forecast, by End User
11.17.1. CDMO
11.17.2. Biotechnology
11.17.3. Pharmaceutical
11.18. North America Bioprocess Validation Market Attractiveness Analysis
11.18.1. By Test Type
11.18.2. By Process Component
11.18.3. By End User
11.19. PEST Analysis
11.20. Key Trends
11.21. Key Development

12. Europe Bioprocess Validation Market Analysis
12.1. Key Findings
12.2. Europe Bioprocess Validation Market Overview
12.3. Europe Bioprocess Validation Market Value Share Analysis, By Test Type
12.4. Europe Bioprocess Validation Market Forecast, By Test Type
12.4.1. Extractables and Leachables
12.4.2. Integrity Testing
12.4.3. Microbiology Testing
12.5. Europe Bioprocess Validation Market Value Share Analysis, By Process Component
12.6. Europe Bioprocess Validation Market Forecast, By Process Component
12.6.1. Filter Element
12.6.2. Bioreactors
12.7. Europe Bioprocess Validation Market Value Share Analysis, by End User
12.8. Europe Bioprocess Validation Market Forecast, by End User
12.8.1. CDMO
12.8.2. Biotechnology
12.8.3. Pharmaceutical
12.9. Europe Bioprocess Validation Market Value Share Analysis, by Country
12.10. Europe Bioprocess Validation Market Forecast, by Country
12.10.1. Germany
12.10.2. U.K.
12.10.3. France
12.10.4. Italy
12.10.5. Spain
12.10.6. Rest of Europe
12.11. Europe Bioprocess Validation Market Analysis, by Country
12.12. Germany Bioprocess Validation Market Forecast, By Test Type
12.12.1. Extractables and Leachables
12.12.2. Integrity Testing
12.12.3. Microbiology Testing
12.13. Germany Bioprocess Validation Market Forecast, By Process Component
12.13.1. Filter Element
12.13.2. Bioreactors
12.14. Germany Bioprocess Validation Market Forecast, by End User
12.14.1. CDMO
12.14.2. Biotechnology
12.14.3. Pharmaceutical
12.15. U.K. Bioprocess Validation Market Forecast, By Test Type
12.15.1. Extractables and Leachables
12.15.2. Integrity Testing
12.15.3. Microbiology Testing
12.16. U.K. Bioprocess Validation Market Forecast, By Process Component
12.16.1. Filter Element
12.16.2. Bioreactors
12.17. U.K. Bioprocess Validation Market Forecast, by End User
12.17.1. CDMO
12.17.2. Biotechnology
12.17.3. Pharmaceutical
12.18. France Bioprocess Validation Market Forecast, By Test Type
12.18.1. Extractables and Leachables
12.18.2. Integrity Testing
12.18.3. Microbiology Testing
12.19. France Bioprocess Validation Market Forecast, By Process Component
12.19.1. Filter Element
12.19.2. Bioreactors
12.20. France Bioprocess Validation Market Forecast, by End User
12.20.1. CDMO
12.20.2. Biotechnology
12.20.3. Pharmaceutical
12.21. Italy Bioprocess Validation Market Forecast, By Test Type
12.21.1. Extractables and Leachables
12.21.2. Integrity Testing
12.21.3. Microbiology Testing
12.22. Italy Bioprocess Validation Market Forecast, By Process Component
12.22.1. Filter Element
12.22.2. Bioreactors
12.23. Italy Bioprocess Validation Market Forecast, by End User
12.23.1. CDMO
12.23.2. Biotechnology
12.23.3. Pharmaceutical
12.24. Spain Bioprocess Validation Market Forecast, By Test Type
12.24.1. Extractables and Leachables
12.24.2. Integrity Testing
12.24.3. Microbiology Testing
12.25. Spain Bioprocess Validation Market Forecast, By Process Component
12.25.1. Filter Element
12.25.2. Bioreactors
12.26. Spain Bioprocess Validation Market Forecast, by End User
12.26.1. CDMO
12.26.2. Biotechnology
12.26.3. Pharmaceutical
12.27. Rest of Europe Bioprocess Validation Market Forecast, By Test Type
12.27.1. Extractables and Leachables
12.27.2. Integrity Testing
12.27.3. Microbiology Testing
12.28. Rest of Europe Bioprocess Validation Market Forecast, By Process Component
12.28.1. Filter Element
12.28.2. Bioreactors
12.29. Rest of Europe Bioprocess Validation Market Forecast, by End User
12.29.1. CDMO
12.29.2. Biotechnology
12.29.3. Pharmaceutical
12.30. Europe Bioprocess Validation Market Attractiveness Analysis
12.30.1. By Test Type
12.30.2. By Process Component
12.30.3. By End User
12.31. PEST Analysis
12.32. Key Trends
12.33. Key Development

13. Asia Pacific Bioprocess Validation Market Analysis
13.1. Key Findings
13.2. Asia Pacific Bioprocess Validation Market Overview
13.3. Asia Pacific Bioprocess Validation Market Value Share Analysis, By Test Type
13.4. Asia Pacific Bioprocess Validation Market Forecast, By Test Type
13.4.1. Extractables and Leachables
13.4.2. Integrity Testing
13.4.3. Microbiology Testing
13.5. Asia Pacific Bioprocess Validation Market Value Share Analysis, By Process Component
13.6. Asia Pacific Bioprocess Validation Market Forecast, By Process Component
13.6.1. Filter Element
13.6.2. Bioreactors
13.7. Asia Pacific Bioprocess Validation Market Value Share Analysis, by End User
13.8. Asia Pacific Bioprocess Validation Market Forecast, by End User
13.8.1. CDMO
13.8.2. Biotechnology
13.8.3. Pharmaceutical
13.9. Asia Pacific Bioprocess Validation Market Value Share Analysis, by Country
13.10. Asia Pacific Bioprocess Validation Market Forecast, by Country
13.10.1. China
13.10.2. India
13.10.3. Japan
13.10.4. ASEAN
13.10.5. Rest of Asia Pacific
13.11. Asia Pacific Bioprocess Validation Market Analysis, by Country
13.12. China Bioprocess Validation Market Forecast, By Test Type
13.12.1. Extractables and Leachables
13.12.2. Integrity Testing
13.12.3. Microbiology Testing
13.13. China Bioprocess Validation Market Forecast, By Process Component
13.13.1. Filter Element
13.13.2. Bioreactors
13.14. China Bioprocess Validation Market Forecast, by End User
13.14.1. CDMO
13.14.2. Biotechnology
13.14.3. Pharmaceutical
13.15. India Bioprocess Validation Market Forecast, By Test Type
13.15.1. Extractables and Leachables
13.15.2. Integrity Testing
13.15.3. Microbiology Testing
13.16. India Bioprocess Validation Market Forecast, By Process Component
13.16.1. Filter Element
13.16.2. Bioreactors
13.17. India Bioprocess Validation Market Forecast, by End User
13.17.1. CDMO
13.17.2. Biotechnology
13.17.3. Pharmaceutical
13.18. Japan Bioprocess Validation Market Forecast, By Test Type
13.18.1. Extractables and Leachables
13.18.2. Integrity Testing
13.18.3. Microbiology Testing
13.19. Japan Bioprocess Validation Market Forecast, By Process Component
13.19.1. Filter Element
13.19.2. Bioreactors
13.20. Japan Bioprocess Validation Market Forecast, by End User
13.20.1. CDMO
13.20.2. Biotechnology
13.20.3. Pharmaceutical
13.21. ASEAN Bioprocess Validation Market Forecast, By Test Type
13.21.1. Extractables and Leachables
13.21.2. Integrity Testing
13.21.3. Microbiology Testing
13.22. ASEAN Bioprocess Validation Market Forecast, By Process Component
13.22.1. Filter Element
13.22.2. Bioreactors
13.23. ASEAN Bioprocess Validation Market Forecast, by End User
13.23.1. CDMO
13.23.2. Biotechnology
13.23.3. Pharmaceutical
13.24. Rest of Asia Pacific Bioprocess Validation Market Forecast, By Test Type
13.24.1. Extractables and Leachables
13.24.2. Integrity Testing
13.24.3. Microbiology Testing
13.25. Rest of Asia Pacific Bioprocess Validation Market Forecast, By Process Component
13.25.1. Filter Element
13.25.2. Bioreactors
13.26. Rest of Asia Pacific Bioprocess Validation Market Forecast, by End User
13.26.1. CDMO
13.26.2. Biotechnology
13.26.3. Pharmaceutical
13.27. Asia Pacific Bioprocess Validation Market Attractiveness Analysis
13.27.1. By Test Type
13.27.2. By Process Component
13.27.3. By End User
13.28. PEST Analysis
13.29. Key Trends
13.30. Key Development

14. Middle East & Africa Bioprocess Validation Market Analysis
14.1. Key Findings
14.2. Middle East & Africa Bioprocess Validation Market Overview
14.3. Middle East & Africa Bioprocess Validation Market Value Share Analysis, By Test Type
14.4. Middle East & Africa Bioprocess Validation Market Forecast, By Test Type
14.4.1. Extractables and Leachables
14.4.2. Integrity Testing
14.4.3. Microbiology Testing
14.5. Middle East & Africa Bioprocess Validation Market Value Share Analysis, By Process Component
14.6. Middle East & Africa Bioprocess Validation Market Forecast, By Process Component
14.6.1. Filter Element
14.6.2. Bioreactors
14.7. Middle East & Africa Bioprocess Validation Market Value Share Analysis, by End User
14.8. Middle East & Africa Bioprocess Validation Market Forecast, by End User
14.8.1. CDMO
14.8.2. Biotechnology
14.8.3. Pharmaceutical
14.9. Middle East & Africa Bioprocess Validation Market Value Share Analysis, by Country
14.10. Middle East & Africa Bioprocess Validation Market Forecast, by Country
14.10.1. GCC
14.10.2. South Africa
14.10.3. Rest of Middle East & Africa
14.11. Middle East & Africa Bioprocess Validation Market Analysis, by Country
14.12. GCC Bioprocess Validation Market Forecast, By Test Type
14.12.1. Extractables and Leachables
14.12.2. Integrity Testing
14.12.3. Microbiology Testing
14.13. GCC Bioprocess Validation Market Forecast, By Process Component
14.13.1. Filter Element
14.13.2. Bioreactors
14.14. GCC Bioprocess Validation Market Forecast, by End User
14.14.1. CDMO
14.14.2. Biotechnology
14.14.3. Pharmaceutical
14.15. South Africa Bioprocess Validation Market Forecast, By Test Type
14.15.1. Extractables and Leachables
14.15.2. Integrity Testing
14.15.3. Microbiology Testing
14.16. South Africa Bioprocess Validation Market Forecast, By Process Component
14.16.1. Filter Element
14.16.2. Bioreactors
14.17. South Africa Bioprocess Validation Market Forecast, by End User
14.17.1. CDMO
14.17.2. Biotechnology
14.17.3. Pharmaceutical
14.18. Rest of Middle East & Africa Bioprocess Validation Market Forecast, By Test Type
14.18.1. Extractables and Leachables
14.18.2. Integrity Testing
14.18.3. Microbiology Testing
14.19. Rest of Middle East & Africa Bioprocess Validation Market Forecast, By Process Component
14.19.1. Filter Element
14.19.2. Bioreactors
14.20. Rest of Middle East & Africa Bioprocess Validation Market Forecast, by End User
14.20.1. CDMO
14.20.2. Biotechnology
14.20.3. Pharmaceutical
14.21. Middle East & Africa Bioprocess Validation Market Attractiveness Analysis
14.21.1. By Test Type
14.21.2. By Process Component
14.21.3. By End User
14.22. PEST Analysis
14.23. Key Trends
14.24. Key Development

15. South America Bioprocess Validation Market Analysis
15.1. Key Findings
15.2. South America Bioprocess Validation Market Overview
15.3. South America Bioprocess Validation Market Value Share Analysis, By Test Type
15.4. South America Bioprocess Validation Market Forecast, By Test Type
15.4.1. Extractables and Leachables
15.4.2. Integrity Testing
15.4.3. Microbiology Testing
15.5. South America Bioprocess Validation Market Value Share Analysis, By Process Component
15.6. South America Bioprocess Validation Market Forecast, By Process Component
15.6.1. Filter Element
15.6.2. Bioreactors
15.7. South America Bioprocess Validation Market Value Share Analysis, by End User
15.8. South America Bioprocess Validation Market Forecast, by End User
15.8.1. CDMO
15.8.2. Biotechnology
15.8.3. Pharmaceutical
15.9. South America Bioprocess Validation Market Value Share Analysis, by Country
15.10. South America Bioprocess Validation Market Forecast, by Country
15.10.1. Brazil
15.10.2. Mexico
15.10.3. Rest of South America
15.11. South America Bioprocess Validation Market Analysis, by Country
15.12. Brazil Bioprocess Validation Market Forecast, By Test Type
15.12.1. Extractables and Leachables
15.12.2. Integrity Testing
15.12.3. Microbiology Testing
15.13. Brazil Bioprocess Validation Market Forecast, By Process Component
15.13.1. Filter Element
15.13.2. Bioreactors
15.14. Brazil Bioprocess Validation Market Forecast, by End User
15.14.1. CDMO
15.14.2. Biotechnology
15.14.3. Pharmaceutical
15.15. Mexico Bioprocess Validation Market Forecast, By Test Type
15.15.1. Extractables and Leachables
15.15.2. Integrity Testing
15.15.3. Microbiology Testing
15.16. Mexico Bioprocess Validation Market Forecast, By Process Component
15.16.1. Filter Element
15.16.2. Bioreactors
15.17. Mexico Bioprocess Validation Market Forecast, by End User
15.17.1. CDMO
15.17.2. Biotechnology
15.17.3. Pharmaceutical
15.18. Rest of South America Bioprocess Validation Market Forecast, By Test Type
15.18.1. Extractables and Leachables
15.18.2. Integrity Testing
15.18.3. Microbiology Testing
15.19. Rest of South America Bioprocess Validation Market Forecast, By Process Component
15.19.1. Filter Element
15.19.2. Bioreactors
15.20. Rest of South America Bioprocess Validation Market Forecast, by End User
15.20.1. CDMO
15.20.2. Biotechnology
15.20.3. Pharmaceutical
15.21. South America Bioprocess Validation Market Attractiveness Analysis
15.21.1. By Test Type
15.21.2. By Process Component
15.21.3. By End User
15.22. PEST Analysis
15.23. Key Trends
15.24. Key Development

16. Company Profiles
16.1. Market Share Analysis, by Company
16.2. Competition Matrix
16.2.1. Competitive Benchmarking of key players by price, presence, market share, Applications and R&D investment
16.2.2. New Product Launches and Product Enhancements
16.2.3. Market Consolidation
16.2.3.1. M&A by Regions, Investment and Applications
16.2.3.2. M&A Key Players, Forward Integration and Backward
Integration
16.3. Company Profiles: Key Players
16.3.1. Merck KGaA (Germany)
16.3.1.1. Company Overview
16.3.1.2. Financial Overview
16.3.1.3. Product Portfolio
16.3.1.4. Business Strategy
16.3.1.5. Recent Developments
16.3.1.6. Company Footprint
16.3.2 SGS S.A. (Switzerland)
16.3.3 Eurofins Scientific (Luxembourg)
16.3.4 Sartorius Stedim Biotech (France)
16.3.5 Pall Corporation (US)
16.3.6 Cobetter Filtration Equipments Co., Ltd. (China)
16.3.7 Toxikon Corporation (US)
16.3.8 DOC S.r.l. (Italy)
16.3.9 MEISSNER FILTRATION PRODUCTS, INC. (US)
16.3.10 Thermo Fisher Scientific (US)
16.3.11 Danher Corporation
16.3.12 Porvair Plc
16.3.13 Almac Group
16.3.14 Biozeen
16.3.15 Werum IT Solutions 
16.3.16 Eurofins Spinnovation Analytical
16.3.17 BioPharm Process Associates, LLC

17. Primary Key Insights
  • INQUIRE BEFORE BUYING